COVID Corruption News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on COVID corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Coronavirus Information Center.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

A shouting match broke out in the White House Situation Room between Health and Human Services Secretary Alex Azar and an Office of Management and Budget official. Azar had asked OMB ... for $2 billion to buy respirator masks and other supplies for a depleted federal stockpile of emergency medical equipment. The relief package enacted Friday secured $16 billion for the Strategic National Stockpile. States desperate for materials from the stockpile are encountering a beleaguered system beset by years of underfunding, changing lines of authority, confusion over the allocation of supplies and a lack of transparency from the administration. The stockpile holds masks, drugs, ventilators and other items in secret sites around the country. It has become a source of growing frustration for many state and hospital officials who are having trouble buying — or even locating — crucial equipment on their own. Massachusetts ... has received 17 percent of the protective gear it requested. Maine requested a half-million N95 specialized protective masks and received 25,558 — about 5 percent of what it sought. Florida has been an exception in its dealings with the stockpile: The state submitted a request on March 11 for 430,000 surgical masks, 180,000 N95 respirators, 82,000 face shields and 238,000 gloves, among other supplies — and received a shipment with everything three days later. President Trump repeatedly has warned states not to complain about how much they are receiving.

Note: This 2018 Washington Post article raises many questions about the secret U.S. stockpile. For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus pandemic from reliable major media sources.

The FBI raised eyebrows on Tuesday when the agency announced that it would not be accepting electronic Freedom of Information Act (FOIA) requests due to the ongoing coronavirus outbreak. As the spread of the virus continues to disrupt normal functions of society like schools, restaurants and sporting events, not many could have predicted that the electronic requests for FBI documents would be affected. "Due to the emerging COVID-19 situation, the FBI is not accepting electronic Freedom of Information/Privacy Act requests or sending out electronic responses through the eFOIPA portal at this time. You may still submit a FOIPA request via standard mail. We apologize for this inconvenience and appreciate your understanding," a red-bolded disclaimer stated on the FBI website. The sudden halt of electronic FOIA requests sparked puzzled reactions on social media. "This is crazy but, then again, FBI and FOIA is a disastrous combo," BuzzFeed senior investigative Jason Leopold tweeted. "The FBI is responding to coronavirus by using it as an opportunity to kill off journalists who really want transparency." They would prefer to receive only those requests laden with all of our germs and whatnot?" Reuters reporter Brad Heath asked.

Note: You can verify this information on the FBI website at this link. For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus pandemic from reliable major media sources.

A journalist writing for The BMJ has won a British Journalism Award for his series on the financial interests of medical experts advising US and UK governments during the covid-19 pandemic. As a result of the articles written by Paul Thacker, an investigative journalist, the financial disclosures of members of the Scientific Advisory Group for Emergencies (SAGE) were published for the first time. Thacker's first story looked at two groups critical to the UK government's pandemic response–SAGE and the Vaccine Taskforce. He examined both and found that they did not disclose their members' financial conflicts. Some members were tied to companies with a monetary interest in the government's purchases. Thacker ... filed freedom of information (FoI) requests with multiple government departments and Oxford University. In a second story he wrote about the government's repeated refusal to turn over these data. However, the FoI ... revealed that Thacker's original request was apparently sent to a special government department to handle any reporter considered a "campaigner" or to have "extreme views." Eventually, the government relented and published the financial conflicts for the members of SAGE. In the final story of the series Thacker looked at the panels that the US and UK governments used to authorize vaccines and revealed that ... disclosure policies were inadequate. Some experts evaluating the vaccines had significant industry ties that were not disclosed.

Note: Read the full text of Thacker's article titled, "Covid-19: How independent were the US and British vaccine advisory committees?" and another titled "How the case of the Oxford professor exposes a transparency crisis in government." For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus from reliable major media sources.

The CDC announced Thursday that it will convene a meeting of its advisers on June 18th to discuss rare but higher-than-expected reports of heart inflammation following doses of the mRNA-based Pfizer and Moderna COVID-19 vaccines. So far, the CDC has identified 226 reports that might meet the agency's "working case definition" of myocarditis and pericarditis following the shots, the agency disclosed Thursday. The CDC first described the panel's session as an "emergency meeting," but later changed it to merely a "COVID-19 meeting." Previous times the advisors convened to discuss the pandemic – like their May 12th gathering to mull recommendations for Pfizer's COVID-19 vaccine in adolescents – were also described as "emergency meetings." The new details about myocarditis and pericarditis emerged first in presentations to a panel of independent advisers for the Food and Drug Administration, who are meeting Thursday to discuss how the regulator should approach emergency use authorization for using COVID-19 vaccines in younger children. The CDC previously disclosed that reports of heart inflammation were detected mostly in younger men and teenage boys following their second dose, and that there was a "higher number of observed than expected" cases in 16- to 24-year-olds. "Risk-benefit considerations … will need to account for this information," [said] Dr. Marion Gruber, director of the FDA's vaccine office."

Note: What this article fails to mention is that for every case reported there are very likely many that go unreported. Explore a much more in-depth article on this. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

Media portrayals of adolescence shape how society views young people and, as positive youth development scholars note, whether they are seen as risks to be managed or resources to be developed. My own research on adolescent mindfulness and virtue inspired me to learn more about how adolescents are faring during the pandemic. Zoya Sethi is a ninth grader from Delhi, India. She and four of her friends observed that after the shutdown of industries in the cities, millions migrated hundreds of kilometers by foot back to their villages, and women had no access to feminine hygiene pads. In response, they began a campaign through Instagram (@we_standwithher). Lucas Hung is a 12th grader from Vancouver, British Columbia. He and four friends similarly used Instagram to raise funds for those in need, with the dual goal of uniting their classmates (@_viralcause_) The teens also found meaning in smaller acts of service that filled critical needs in their communities. “It was so cool to see that something as small as offering to teach a 40-minute online dance class to their kids could make parents’ lives so much better,” explained Devyn Slade, a 12th grade volunteer dance instructor. Teens also empathized with the plight of seniors in retirement communities. One group wrote letters to older adults, “trying to make them feel connected, seen, and loved during this time where they’re facing tons of isolation and fear and hard times,” said Connor Macmillan, a 12th grade water polo player.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

We’re headed into a global depression–a period of economic misery that few living people have experienced. Depressions don’t just generate ugly stats and send buyers and sellers into hibernation. They change the way we live. COVID-19 fears will bring lasting changes to public attitudes toward all activities that involve crowds of people and how we work on a daily basis; it will also permanently change America’s competitive position in the world and raise profound uncertainty about U.S.-China relations going forward. Most postwar U.S. recessions have limited their worst effects to the domestic economy. But most were the result of domestic inflation or a tightening of national credit markets. That is not the case with COVID-19 and the current global slowdown. This is a synchronized crisis, and just as the relentless rise of China over the past four decades has lifted many boats in richer and poorer countries alike, so slowdowns in China, the U.S. and Europe will have global impact on our globalized world. The Congressional Budget Office has warned that the unemployment rate will remain stubbornly high for the next decade, and economic output will remain depressed for years unless changes are made to the way government taxes and spends. Those sorts of changes will depend on broad recognition that emergency measures won’t be nearly enough to restore the U.S. economy to health. What’s true in the U.S. will be true everywhere else.

Note: A CNN article dated Aug. 15th is titled "1 in 4 young people are reporting suicidal thoughts." A USA Today article states, "More than 40% of respondents who completed surveys during June reported an adverse mental or behavioral health condition, and 11% reported having seriously considered suicide in the 30 days prior." It's possible that deaths from suicide, domestic violence, hunger, and more will significantly exceed the number of virus deaths. For more, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Dr. Richard Bartlett works at various clinics around West Texas, and says he’s found a successful treatment for the coronavirus. “The treatment plan is inhaled, generic budesonide,” Bartlett said. “Using some generic antibiotics to protect from a secondary bacterial infection. Using zinc, which interferes with virus replication. It’s common sense. It’s intuitive.” Budesonide is a steroid, that can be inhaled directly to the lungs using a nebulizer. The drug has been used for decades to treat asthma and is approved by the FDA. However using it to treat COVID-19 is not. “I am not aware of any doctors anywhere that are using this specifically for COVID-19, yet,” Bartlett said. Bartlett said he treats people as soon as they show symptoms. “Early treatment is better with this disease,” he said. “And I’m having a 100% survival rate. I don’t even know how many I’ve treated...dozens. I have 14 that I’m treating right now.” Bartlett said that patients tell him they feel immediate relief. Bartlett said he’s currently writing a paper to submit to medical journals. Additionally, he said the National Institute of Health, as well as the countries of France and Spain will be looking into inhaled budesonide treatments.

Note: Watch a fascinating interview with this doctor. And remember that the biggest sponsor of the major media is big Pharma. The don't want any cheap medicine like hydrochlorequine or budesonide to look good. There are other inexpensive treatments that are not being reported. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

The chief scientist brought on to lead the Trump administration's vaccine efforts has spent the last several days trying to disentangle pieces of his stock portfolio and his intricate ties to big pharmaceutical interests. The scientist, Moncef Slaoui, is a venture capitalist and a former longtime executive at GlaxoSmithKline. Most recently, he sat on the board of Moderna, a Cambridge, Mass., biotechnology firm with a $30 billion valuation that is pursuing a coronavirus vaccine. He resigned when President Trump named him last Thursday to the new post as chief adviser for Operation Warp Speed, the federal drive for coronavirus vaccines and treatments. Just days into his job, the extent of Dr. Slaoui's financial interests in drug companies has begun to emerge: The value of his stock holdings in Moderna jumped nearly $2.4 million, to $12.4 million when the company released preliminary, partial data from an early phase of its candidate vaccine trial. Dr. Slaoui did not come on board as a government employee. Instead, he is on a contract ... that leaves him exempt from federal disclosure rules that would require him to list his outside positions, stock holdings and other potential conflicts. And the contract position is not subject to the same conflict-of-interest laws and regulations that executive branch employees must follow. Dr. Slaoui ... is not the first Trump administration official with close relationships to drug and health care companies. Alex M. Azar II, the health and human services secretary, is a former Eli Lilly executive.

Note: If the above link fails, this article is also available here. For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in Big Pharma from reliable major media sources.

With nearly 55,000 confirmed lives lost in the United States so far and widespread economic disruption from the coronavirus, it is increasing apparent that America could learn a thing or two from how other democracies are managing the pandemic. Taiwan, for example, never ordered a lockdown. Its baseball season is in full swing. The country is so flush with pandemic supplies that it is exporting 10 million masks to America and elsewhere. Under Iceland's "lockdown lite," kindergartens and elementary schools are on limited operations, allowing parents to work. South Korea's malls and restaurants are bustling. Constraints are being eased in New Zealand and in Germany. The rate of coronavirus deaths in these five countries — three of which are led by women — is significantly less than that in the United States, which has lost more people to the virus than any nation and has the world's seventh highest COVID-19 mortality rate. Taiwan, South Korea, Iceland and Germany began stockpiling test kits even before their first coronavirus deaths. The United States, meanwhile, fumbled the creation of a COVID-19 test in February and has been behind ever since. Other nations were innovative and aggressive on testing. Taiwan checked passengers disembarking from cruise ships and retested patients diagnosed with influenza or pneumonia to ensure no mistakes were made. South Korea launched drive-thru diagnostics on Feb. 26. Iceland leads the world in per capita testing, while America ranks 41st.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus pandemic from reliable major media sources.

The statewide order to shelter in place that went into effect on March 20 had a beneficial side-effect: Accidents, injuries and fatalities on California roadways were cut in half, saving the state and residents of California $1 billion, according to a UC Davis study. In the 22 days after the shelter-in-place order (March 21-April 11), there was an average of 450 vehicle collisions per day throughout the state, according to the study conducted by the Road Ecology Center at UC Davis. During the same period in 2019, there were 1,128 collisions per day. In the 22 days prior to sheltering in place, there were 1,056 accidents per day. “The reduction in traffic crashes, injuries and fatalities is a bit of a silver lining for people who are staying at home and who are impacted by the pandemic,” said ... project lead author Fraser Shilling. "The reduction in numbers of all collisions, injury, and fatal collision was equivalent to a $40 million/day savings in costs and about $1 billion in savings since the Governor’s order went into effect," the study concluded. The figures were calculated using Federal Highway Administration data, which includes savings from "property damage, treatment of injuries, lost time at work, emergency responses, insurance claims, and the equivalent cost of a life." Not surprisingly, the study found that traffic volume decreased 20% to as much as 55%. "There is no equivalent in our recent transportation history to such large changes in vehicle movement on our state and local roads," the study said.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Estimates of [coronavirus] lethality keep going down. On March 31, the White House estimated that, even with social distancing policies in place, between 100,000 and 240,000 Americans would die of covid-19. Anthony S. Fauci recently indicated the government’s estimates will soon be revised downward. Predictions for hospitalization rates have also proved to be substantial overestimations. On March 30, University of Washington researchers projected that California would need 4,800 beds on April 3. In fact, the state needed 2,200. The same model projected that Louisiana would need 6,400; in fact, it used only 1,700. Even New York, the most stressed system in the country, used only 15,000 beds against a projection of 58,000. In March, the World Health Organization announced that 3.4 percent of people with the virus had died from it. That would be an astonishingly high fatality rate. Fauci suggested a week later that the actual rate was probably 1 percent. [Yet] some studies find that 75 to 80 percent of people infected could be asymptomatic. That means most people infected with the virus ... never get counted. Standford's John Ioannidis, ... one of the most cited scientists in the field, believes we have massively overestimated the fatality of covid-19. “Iif you make a small mistake in the base numbers, you end up with a final number that could be off 10-fold, 30-fold, even 50-fold,” he [said]. South Korea has been able to tackle the virus without lockdowns precisely because it has handled testing superbly. We have shut down the economy based on models. But models are only as good as the data that shapes them.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Michael Levitt, a Nobel laureate and Stanford biophysicist, began analyzing the number of COVID-19 cases worldwide in January and correctly calculated that China would get through the worst of its coronavirus outbreak long before many health experts had predicted. Now he foresees a similar outcome in the United States and the rest of the world. While many epidemiologists are warning of months, or even years, of massive social disruption and millions of deaths, Levitt says the data simply don’t support such a dire scenario — especially in areas where reasonable social distancing measures are in place. “What we need is to control the panic,” he said. In the grand scheme, “we’re going to be fine.” Here’s what Levitt noticed in China: On Jan. 31, the country had 46 new deaths due to the novel coronavirus, compared with 42 new deaths the day before. Although the number of daily deaths had increased, the rate of that increase had begun to ease off. It was an early sign that the trajectory of the outbreak had shifted. “This suggests that the rate of increase in the number of deaths will slow down even more over the next week,” Levitt wrote. He predicted that the total number of confirmed COVID-19 cases in China would end up around 80,000, with about 3,250 deaths. This forecast turned out to be remarkably accurate. Now Levitt ... is seeing similar turning points in other nations. He analyzed data from 78 countries that reported more than 50 new cases of COVID-19 every day and sees “signs of recovery” in many of them.

Note: Consider the research of 12 other experts questioning the coronavirus panic. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus pandemic from reliable major media sources.

Before a vaccine to combat the coronavirus pandemic is within view, the Trump administration has already walked back its initial refusal to promise that any remedy would be affordable to the general public. “We can’t control that price because we need the private sector to invest,” Alex Azar, Health and Human Services secretary and a former drug industry executive, told Congress. After extraordinary blowback, the administration insisted that in the end, any treatment would indeed be affordable. The federal government, though, under the Clinton administration, traded away one of the key tools it could use to make good on the promise of affordability. Gilead Sciences, a drugmaker known for price gouging, has been working with Chinese health authorities to see if the experimental drug remdesivir can treat coronavirus symptoms. But remdesivir, which was previously tested to treat Ebola virus, was developed through research conducted at the University of Alabama ... with funding from the federal government. That’s how much of the pharmaceutical industry’s research and development is funded. The public puts in the money, and private companies keep whatever profits they can. It wasn’t always that way. Before 1995, drug companies were required to sell drugs funded with public money at a reasonable price. Under the Clinton administration, that changed. In April 1995, the Clinton administration capitulated to pharmaceutical industry pressure and rescinded the longstanding “reasonable pricing” rule.

Note: Read an excellent post by an infectious disease doctor saying he's much more concerned about the fear and panic around the Coronavirus than about the virus itself. For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

Shanghai Disney has become the latest high-profile venue to shut its gates thanks to China's strict zero-Covid policy, trapping visitors inside. People have been told they will not be allowed out of the theme park until they can show a negative test. China's controversial zero-Covid policy has already seen millions of people repeatedly locked down, sometimes in unusual locations. The sudden nature lockdowns have seen people fleeing shops - including a Shanghai branch of Swedish furniture giant Ikea - and workplaces as they try to avoid being trapped inside. However, those awaiting their freedom at Shanghai Disney can console themselves with one positive: rides are continuing to operate for those trapped inside The Happiest Place on Earth. As well as the theme park, surrounding areas such as the shopping street were also abruptly closed. Videos posted on Chinese social media site Weibo showed people rushing to the park's gates following the announcement but finding them already locked. Posting on Chinese social media site WeChat, the Shanghai government said the park was barring people from entering and those inside could only leave once they had returned a negative test result. It added that anyone who has visited the park since Thursday must provide three negative test results over three consecutive days. Millions of people are under 200 different lockdowns in China, as of October 24, as the country of 1.45 billion consistently records more than 1,000 new Covid cases a day.

Note: By comparison, the U.S. had about 40,000 cases per day in late October. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Detroit's city council will soon vote on whether to spend millions in federal cash meant to ease the economic pains of the coronavirus pandemic on ShotSpotter, a controversial surveillance technology critics say is invasive, discriminatory, and fundamentally broken. ShotSpotter purports to do one thing very well: telling cops a gun has been fired as soon as the trigger is pulled. Using a network of microphones hitched to telephone poles, rooftops, and other urban vantage points, ShotSpotter is essentially an Alexa that listens for a bang rather than voice commands. Despite ShotSpotter's corporate claims of 97 percent accuracy, the technology's efficacy has been derided as dangerously ineffective – a techno-solutionist approach to public safety. ShotSpotter's opponents in Detroit agreed that gun violence is a serious problem but said Covid-19 relief money would be far better spent on addressing the social ills that form the basis of crime. "If people had jobs, money, after-school programs, housing, the things that they need, that's going to reduce gun violence," said Alyx Goodwin, a campaign organizer with Action Center on Race and the Economy. Snyder pointed to the fundamental irony of diverting public money billed as form of relief for the pandemic's downtrodden to surveil those very same people. ShotSpotter explicitly urges cities to tap funds from the American Rescue Plan Act, intended to salve financial hardship caused by the pandemic, to buy new surveillance microphones.

Note: For more along these lines, see concise summaries of deeply revealing news articles on police corruption and the coronavirus from reliable major media sources.

White House COVID-19 Response Team Coordinator Dr. Ashish Jha said during a virtual discussion Tuesday that the way we used to think about social distancing is "not actually the right way" to think about COVID-19 mitigation. The response came when U.S. Chamber of Commerce President Suzanne Clarke asked Jha what prompted the Centers for Disease Control and Prevention to update their COVID-19 guidance, and to clarify exactly what that guidance is now. "The CDC guidance sort of relaxes a lot of the restrictions we've had," Jha responded. "Tells us that there's a really new way of thinking about who is going to get infected. We used to spend a lot of time talking about six feet of distance, 15 minutes of being together. You know, we realize that's actually not the right way to think about this, that's not the kind of – most accurate way to think about this." Jha said that, instead ... it's really about the quality of air you're breathing around you. "A crowded indoor space with poor ventilation, you can get infected within minutes," Jha continued "If you're outdoors, with obviously by definition good ventilation, you can be outside for long periods of time and not get infected. So, context matters, crowds matter, ventilation matters." The latest CDC guidance says social distancing is "just one component of how to protect yourself and others" from COVID-19. The deemphasis on social distance marks a shift in the CDC's messaging, which had long prioritized social distancing as a critical mitigation strategy.

Note: If anyone made these comments in 2021, they would likely have been censored. For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus from reliable major media sources.

At this point, one thing about the pandemic is clear: The COVID-19 vaccines, even when followed by a booster, aren't going to stop the coronavirus – or provide long-term protection from infections. Right after the third shot – the booster – antibodies rise up quickly. But then about a month later, they begin to decline. As a result, protection against infection drops down to about 50% three months later. So the question is: Should you get a fourth dose to beef up protection again? A preliminary study from Israel ... suggests that for the general population, the answer is likely no. A fourth shot of the same vaccine – in this case Pfizer-BioNTech or Moderna – offered very little extra protection against infection compared with only three shots. "Not a third dose, not a fourth dose, not a fifth dose will do anything to stop infections [long term]," says Dr. Gili Regev-Yochay, an infectious disease specialist at Sheba Medical Center in Tel HaShomer, Israel, and lead author of the new study. Regev-Yochay and her team gave about 300 health care workers a fourth shot, either Pfizer or Moderna. And then they looked to see if those people were less likely to become infected while working at Sheba Medical Center, compared with about 400 health care workers who had received only three shots. The extra dose reduced the risk of an infection by only about 10% to 30%, Regev-Yochay and her team report. The extra dose also didn't appear to activate T cells, which are critical for clearing out a future infection.

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

Previous infection with the coronavirus appeared to provide stronger protection against the Delta variant than did vaccination in a large sample of patients, the Centers for Disease Control and Prevention reported. Scientists analyzed testing, surveillance and immunization data from the [New York and California] to gauge the level of protection offered by vaccines and previous infection. During the week beginning May 30, 2021, vaccinated people who had not experienced Covid had the lowest risk of coronavirus infection and hospitalization, followed by unvaccinated people who had been previously diagnosed with Covid. By the week beginning Oct. 3, however, vaccinated people with a prior diagnosis fared best against the Delta variant. Unvaccinated people with a history of Covid also had lower rates of infection and hospitalization than those protected by vaccines alone. Waning of vaccine-derived immunity may explain why vaccinated people were less protected from infection with the Delta variant than those who had a prior diagnosis. A recent study of employees at the Cleveland Clinic suggested that ... vaccination does not add much benefit to a prior bout for the first many months.

Note: The full article is strongly biased towards vaccination, yet the data shows that prior exposure to COVID often provides better protection than the vaccines, whose protection clearly wanes over time. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

Previous infection with the coronavirus appeared to provide stronger protection against the Delta variant than did vaccination in a large sample of patients, the Centers for Disease Control and Prevention reported. Scientists analyzed testing, surveillance and immunization data from the [New York and California] to gauge the level of protection offered by vaccines and previous infection. During the week beginning May 30, 2021, vaccinated people who had not experienced Covid had the lowest risk of coronavirus infection and hospitalization, followed by unvaccinated people who had been previously diagnosed with Covid. By the week beginning Oct. 3, however, vaccinated people with a prior diagnosis fared best against the Delta variant. Unvaccinated people with a history of Covid also had lower rates of infection and hospitalization than those protected by vaccines alone. Waning of vaccine-derived immunity may explain why vaccinated people were less protected from infection with the Delta variant than those who had a prior diagnosis. A recent study of employees at the Cleveland Clinic suggested that ... vaccination does not add much benefit to a prior bout for the first many months.

Note: The full article is strongly biased towards vaccination, yet the data shows that prior exposure to COVID often provides better protection than the vaccines, whose protection clearly wanes over time. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

The five most vaccinated states in the United States–Vermont, Rhode Island, Maine, Connecticut and Massachusetts–are all experiencing surges in new COVID-19 cases, as the Biden administration urges people over 50 to get their booster jabs. Vermont, which is the most vaccinated state, with 73 percent of its population fully jabbed, saw an 18 percent rise in new daily COVID cases over the last 14 days before November 24, according to New York Times data. The northeastern state recorded an average of 370 new COVID-19 cases a day over the past week before Wednesday. Rhode Island, which is 72 percent vaccinated, saw a 69 percent rise in new cases during that same 14-day time period. The state recorded an average of 480 new cases a day between November 17-24. Maine, also 72 percent vaccinated, saw a 35 percent rise (now 694 daily average of new cases), while Connecticut, which is 72 percent vaccinated, saw a 120 percent spike in daily COVID cases (now 751 daily average of new cases). Massachusetts, which is 71 percent vaccinated, saw a rise of 81 percent during the last 14 days before November 24. On average, it has recorded 2,881 cases a day between November 17-24. On Tuesday, the U.S. recorded 100,636 new cases of COVID-19. National daily cases have been rising since October 24, the data shows, where only 23,596 cases were reported. Sixty-nine percent of all Americans aged 12 and older have had two shots of the vaccine.

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.